200,000+ products from a single source!

sales@angenechem.com

Home > Carboxes > 211110-63-3

211110-63-3

211110-63-3 | Acetic acid, 2-[4-[[4-hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]-

CAS No: 211110-63-3 Catalog No: AG002L62 MDL No:MFCD19443713

Product Description

Catalog Number:
AG002L62
Chemical Name:
Acetic acid, 2-[4-[[4-hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]-
CAS Number:
211110-63-3
Molecular Formula:
C20H24O4
Molecular Weight:
328.4022
MDL Number:
MFCD19443713
IUPAC Name:
2-[4-[(4-hydroxy-3-propan-2-ylphenyl)methyl]-3,5-dimethylphenoxy]acetic acid
InChI:
InChI=1S/C20H24O4/c1-12(2)17-9-15(5-6-19(17)21)10-18-13(3)7-16(8-14(18)4)24-11-20(22)23/h5-9,12,21H,10-11H2,1-4H3,(H,22,23)
InChI Key:
QNAZTOHXCZPOSA-UHFFFAOYSA-N
SMILES:
OC(=O)COc1cc(C)c(c(c1)C)Cc1ccc(c(c1)C(C)C)O
UNII:
XQ31741E9Q

Properties

Complexity:
396  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
328.167g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
328.408g/mol
Monoisotopic Mass:
328.167g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
66.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.9  

Literature

Title Journal
Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1. Endocrinology 20120101
The binding of synthetic triiodo l-thyronine analogs to human transthyretin: molecular basis of cooperative and non-cooperative ligand recognition. Journal of structural biology 20110201
Sobetirome: a selective thyromimetic for the treatment of dyslipidemia. Recent patents on cardiovascular drug discovery 20110101
Thyroid hormones, mitochondrial bioenergetics and lipid handling. Current opinion in endocrinology, diabetes, and obesity 20101001
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells. Journal of hepatology 20101001
The T3 receptor beta1 isoform regulates UCP1 and D2 deiodinase in rat brown adipocytes. Endocrinology 20101001
Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA). Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20100601
The TRbeta-selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine. The Journal of endocrinology 20100601
Sobetirome: a case history of bench-to-clinic drug discovery and development. Heart failure reviews 20100301
The resurgence of thyromimetics as lipid-modifying agents. Current opinion in investigational drugs (London, England : 2000) 20090901
Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics. The Journal of steroid biochemistry and molecular biology 20090801
The thyroid hormone receptor (TR) beta-selective agonist GC-1 inhibits proliferation but induces differentiation and TR beta mRNA expression in mouse and rat osteoblast-like cells. Calcified tissue international 20090401
T3 and the thyroid hormone beta-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues. The Journal of experimental biology 20090401
Thyroid hormone receptor subtype specificity for hormone-dependent neurogenesis in Xenopus laevis. Developmental biology 20090201
Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology (Baltimore, Md.) 20090201
Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs. Journal of medicinal chemistry 20081127
[Thyroid hormone analogs: an important biological supply and new therapeutic possibilities]. Annales d'endocrinologie 20080901
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20080801
Thyroid hormone analogues: useful biological probes and potential therapeutic agents. Annales d'endocrinologie 20080401
Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms. BMC structural biology 20080101
Influence of thyroid hormone and thyroid hormone receptors in the generation of cerebellar gamma-aminobutyric acid-ergic interneurons from precursor cells. Endocrinology 20071201
Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. The Journal of endocrinology 20070401
A phosphorimager-based filter binding thyroid hormone receptor competition assay for chemical screening. Journal of pharmacological and toxicological methods 20070101
The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas. Endocrinology 20060701
Analysis of thyroid hormone receptor betaA mRNA expression in Xenopus laevis tadpoles as a means to detect agonism and antagonism of thyroid hormone action. Toxicology and applied pharmacology 20060401
Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression. Endocrinology 20051101
The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. Journal of cardiovascular pharmacology 20050901
Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone. Biochemistry 20050329
The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050201
Thyroid hormone-dependent seasonality in American tree sparrows (Spizella arborea): effects of GC-1, a thyroid receptor beta-selective agonist, and of iopanoic acid, a deiodinase inhibitor. Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20040801
Induction of larval tissue resorption in Xenopus laevis tadpoles by the thyroid hormone receptor agonist GC-1. The Journal of biological chemistry 20040618
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine. Endocrinology 20040401
Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight. Trends in endocrinology and metabolism: TEM 20040101
Differential effects of triiodothyronine and the thyroid hormone receptor beta-specific agonist GC-1 on thyroid hormone target genes in the b ain. Endocrinology 20031201
Structural determinants of selective thyromimetics. Journal of medicinal chemistry 20030703
Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment. Journal of medicinal chemistry 20020718
Synthesis and biological activity of novel thyroid hormone analogues: 5'-aryl substituted GC-1 derivatives. Bioorganic & medicinal chemistry 20020201
A designed antagonist of the thyroid hormone receptor. Bioorganic & medicinal chemistry letters 20011105
Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circulation research 20010928
Thyroid hormone--sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform--specific. The Journal of clinical investigation 20010701
Hormone selectivity in thyroid hormone receptors. Molecular endocrinology (Baltimore, Md.) 20010301
A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chemistry & biology 19980601
Binding of 3,5,3'-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the alpha- and beta-forms for the acetic acid analog and failure of the human testis and kidney alpha-2 products to bind T3. Molecular endocrinology (Baltimore, Md.) 19900201
Opiate-dependent modulation of adenylate cyclase. Proceedings of the National Academy of Sciences of the United States of America 19770801

© 2019 Angene International Limited. All rights Reserved.